Otsuka and Click Therapeutics’ Rejoyn has become the first prescription digital therapeutic (DTx) to be approved by the FDA for people with major depressive disorder. Rejoyn (formerly CT-152), a ...

Digital health company Better Therapeutics has submitted its lead prescription digital therapeutic (DTx) BT-001 to the FDA, seeking approval for use by adults with type 2 diabetes (T2D).

If you’re looking to dramatically change a room but don’t want to spend a lot of money, time, or even be especially committed to the results, consider removable wallpaper — specifically the ...

The history of wallpaper is not simply a history of ornamental patterns and designs. It is also a fascinating record of technological ingenuity and changes in patterns of consumption and domestic ...